BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11262663)

  • 1. The molecular biology of retinoblastoma.
    Brantley MA; Harbour JW
    Ocul Immunol Inflamm; 2001 Mar; 9(1):1-8. PubMed ID: 11262663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
    Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
    Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of low-penetrance retinoblastoma.
    Harbour JW
    Arch Ophthalmol; 2001 Nov; 119(11):1699-704. PubMed ID: 11709023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
    Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
    Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between Rb and Arf in suppressing mouse retinoblastoma.
    Conkrite K; Sundby M; Mu D; Mukai S; MacPherson D
    J Clin Invest; 2012 May; 122(5):1726-33. PubMed ID: 22484813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.
    Allaman-Pillet N; Oberson A; Schorderet DF
    Oncotarget; 2017 Feb; 8(9):15490-15506. PubMed ID: 28099942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer.
    DiCiommo D; Gallie BL; Bremner R
    Semin Cancer Biol; 2000 Aug; 10(4):255-69. PubMed ID: 10966849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
    Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
    Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rb pathway and cancer therapeutics.
    Du W; Searle JS
    Curr Drug Targets; 2009 Jul; 10(7):581-9. PubMed ID: 19601762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation.
    Nittner D; Lambertz I; Clermont F; Mestdagh P; Köhler C; Nielsen SJ; Jochemsen A; Speleman F; Vandesompele J; Dyer MA; Schramm A; Schulte JH; Marine JC
    Nat Cell Biol; 2012 Sep; 14(9):958-65. PubMed ID: 22864477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers.
    Martínez-Sánchez M; Moctezuma-Dávila M; Hernandez-Monge J; Rangel-Charqueño M; Olivares-Illana V
    PLoS One; 2020; 15(6):e0234337. PubMed ID: 32502182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pRB detection as a common event in human retinoblastomas: an immunohistochemical study.
    Rodríguez-Cruz M; Sanchez R; Arenas D; Coral-Vazquez R; Velazquez AC; Ramón-García G; Siordia G; Salamanca F; Salcedo M
    Acta Histochem; 2008; 110(2):109-16. PubMed ID: 17963824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors.
    Kratzke RA; Otterson GA; Hogg A; Coxon AB; Geradts J; Cowell JK; Kaye FJ
    Oncogene; 1994 May; 9(5):1321-6. PubMed ID: 8152792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.
    Singh HP; Wang S; Stachelek K; Lee S; Reid MW; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9391-E9400. PubMed ID: 30213853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
    Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
    J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From gene to disease; retinoblastoma and the RB1 gene].
    Scheffer H; Imhof SM; Moll AC
    Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1245-7. PubMed ID: 11455690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the retinoblastoma protein in the pathogenesis of human cancer.
    Sellers WR; Kaelin WG
    J Clin Oncol; 1997 Nov; 15(11):3301-12. PubMed ID: 9363859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
    Yang Y; Mei Q
    Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic perspective of retinoblastoma: From present to future.
    Jagadeesan M; Khetan V; Mallipatna A
    Indian J Ophthalmol; 2016 May; 64(5):332-6. PubMed ID: 27380971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications.
    Lee C; Kim JK
    J Cell Physiol; 2021 Apr; 236(4):2318-2332. PubMed ID: 32840881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.